InvestorsHub Logo
Followers 50
Posts 5163
Boards Moderated 0
Alias Born 02/05/2016

Re: learningcurve2020 post# 638879

Monday, 10/09/2023 1:25:22 PM

Monday, October 09, 2023 1:25:22 PM

Post# of 708340

Tell me, do you think publicly released news of trial results where the drug/ vaccine is allegedly running silent under another name but only some folks know it, is proper and not a material event to be PR'd?



No, it's not material, because NWBO is not involved in it. UCLA can manufacture the vaccine via their own process in extremely small amounts in house, and therefore NWBO needed not waste time or resources on this.

Tell me, what is the next step for this combo trial? How will UCLA come up with the 10-50 doses necessary per month, when their process currently struggles with two? If only there was a company with the manufacturing IP and facilities to accommodate this....

This is where due diligence and common sense can actually come in handy to help identify a company that is undervalued.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News